TRAMETINIB
Manner of administration:Oral
Restriction (Streamlined authority code: 10051)
Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 3 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17951)
Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
Manner of administration:Oral
Restriction
Indication: Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma
Treatment phase: Initial treatment
Restriction
Indication: Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 3 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
Manner of administration:Oral
Restriction
Indication: Paediatric low grade glioma
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 3 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
Manner of administration:Oral
Restriction
Indication: Paediatric high grade glioma
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 3 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 17286)
Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $7,158.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Mekinist | |||||